{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:40:33Z","timestamp":1792017633077,"version":"4.4.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.annonc.2020.02.012","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T19:03:30Z","timestamp":1585767810000},"page":"558-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":196,"title":["Aspirin and the risk of colorectal and other digestive tract cancers: an\u00a0updated meta-analysis through 2019"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2090-4608","authenticated-orcid":false,"given":"C.","family":"Bosetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gallus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Martinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"La Vecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annonc.2020.02.012_bib1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","article-title":"Aspirin and cancer","volume":"68","author":"Patrignani","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.annonc.2020.02.012_bib2","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/annonc\/mds113","article-title":"Aspirin and cancer risk: a quantitative review to 2011","volume":"23","author":"Bosetti","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2020.02.012_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","article-title":"Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials","volume":"13","author":"Algra","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annonc.2020.02.012_bib4","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.annonc.2020.02.012_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40256-014-0100-5","article-title":"A\u00a0systematic review of aspirin in primary prevention: is it time for a new approach?","volume":"15","author":"Brotons","year":"2015","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.annonc.2020.02.012_bib6","doi-asserted-by":"crossref","first-page":"e57578","DOI":"10.1371\/journal.pone.0057578","article-title":"Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.annonc.2020.02.012_bib7","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.18632\/oncotarget.13591","article-title":"Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: a dose-response meta-analysis","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.annonc.2020.02.012_bib8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12885-018-4156-5","article-title":"Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies","volume":"18","author":"Qiao","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.annonc.2020.02.012_bib9","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.annonc.2020.02.012_bib10","series-title":"Cochrane Handbook for Systematic Reviews of Interventions. version 6.0 (updated July 2019). Cochrane","year":"2019"},{"key":"10.1016\/j.annonc.2020.02.012_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.annonc.2020.02.012_bib12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.annonc.2020.02.012_bib13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/sim.3013","article-title":"Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category","volume":"27","author":"Hamling","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.annonc.2020.02.012_bib14","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research","volume":"29","author":"Desquilbet","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.annonc.2020.02.012_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/aje\/kwr265","article-title":"Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software","volume":"175","author":"Orsini","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.annonc.2020.02.012_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejca.2018.09.007","article-title":"Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis","volume":"104","author":"Lugo","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.annonc.2020.02.012_bib17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1177\/0962280218773122","article-title":"One-stage dose-response meta-analysis for aggregated data","volume":"28","author":"Crippa","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.annonc.2020.02.012_bib18","article-title":"Multivariate dose-response meta-analysis: the dosresmeta R Package","volume":"72","author":"Crippa","year":"2016","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.annonc.2020.02.012_bib19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jama.2015.1815","article-title":"Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants","volume":"313","author":"Nan","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.annonc.2020.02.012_bib20","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.annonc.2020.02.012_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.annonc.2020.02.012_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-128-9-199805010-00003","article-title":"Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study","volume":"128","author":"Sturmer","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annonc.2020.02.012_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.annonc.2020.02.012_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial","volume":"159","author":"Cook","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annonc.2020.02.012_bib25","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","article-title":"Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies","volume":"369","author":"Flossmann","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.annonc.2020.02.012_bib26","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"Burn","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.annonc.2020.02.012_bib27","series-title":"Aspirin Use for the Prevention of Colorectal Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force","author":"Chubak","year":"2015"},{"key":"10.1016\/j.annonc.2020.02.012_bib28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.7326\/M15-2117","article-title":"Aspirin for the prevention of cancer incidence and mortality: systematic evidence reviews for the U.S. Preventive Services Task Force","volume":"164","author":"Chubak","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annonc.2020.02.012_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mdu225","article-title":"Estimates of benefits and harms of prophylactic use of aspirin in the general population","volume":"26","author":"Cuzick","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2020.02.012_bib30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamainternmed.2018.8342","article-title":"Association of daily aspirin therapy with risk of hepatocellular carcinoma in patients with chronic hepatitis B","volume":"179","author":"Lee","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.annonc.2020.02.012_bib31","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/90.20.1529","article-title":"Cyclooxygenase-2 inhibitors in tumorigenesis (part I)","volume":"90","author":"Taketo","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.annonc.2020.02.012_bib32","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/jnci\/90.21.1609","article-title":"Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)","volume":"90","author":"Taketo","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.annonc.2020.02.012_bib33","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(09)60243-9","article-title":"Aspirin, salicylates, and cancer","volume":"373","author":"Elwood","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.annonc.2020.02.012_bib34","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/bjc.2011.289","article-title":"Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?","volume":"105","author":"Langley","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annonc.2020.02.012_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13063-016-1744-z","article-title":"ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial","volume":"18","author":"Drew","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.annonc.2020.02.012_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jacc.2015.05.012","article-title":"The multifaceted clinical readouts of platelet inhibition by low-dose aspirin","volume":"66","author":"Patrono","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420360737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753420360737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:56:03Z","timestamp":1760334963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753420360737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0923753420360737"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2020.02.012","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin and the risk of colorectal and other digestive tract cancers: an\u00a0updated meta-analysis through 2019","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2020.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}]}}